Lenalidomid Grindeks 20 mg tvrde kapsule
| Name | Lenalidomid Grindeks 20 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-537202799 |
| Active Substance | lenalidomid amonijev klorid |
| Composition | jedna kapsula sadrži 20 mg lenalidomida (u obliku lenalidomid amonijevog klorida) |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Grindeks AS, Riga, Latvija |
| Marketing Authorisation Holder | AS Grindeks, Krustpils iela 53, Riga, Latvija |
| Marketing Authorisation Date | 30.10.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/198 |
| Registration Number | 381-12-01/70-24-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L04AX04 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
| Educational materials for healthcare professionals |
Vodic za zdravstvene radnike, verzija 5, travanj 2025 Obrazac za prijavu trudnoće, verzija 3, travanj 2025 Obrazac potvrde bolesnice u reproduktivnoj dobi, verzija 1 travanj 2025 Obrazac potvrde bolesnice koja nije u reproduktivnoj dobi, verzija 1 travanj 2025 Obrazac potvrde muškog bolesnika, verzija 1, travanj 2025 |
| Educational materials for patients / caregivers |
Kartica za bolesnika, verzija 4, travanj 2025 Vodic za bolesnice u reproduktivnoj dobi i njihove partnere, verzija 1 travanj 2025 Vodic za bolesnice koje nisu u reproduktvnoj dobi, verzija 1 travanj 2025 Vodic za muške bolesnike, verzija1, travanj 2025 |
